This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vafiadis, P. Articles by Polychronakos, C. Search for Related Content PubMed PubMed Citation Articles by Vafiadis, P. Articles by Polychronakos, C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Type 1

Class III Alleles of the Variable Number of Tandem Repeat Insulin Polymorphism Associated with Silencing of Thymic Insulin Predispose to Type 1 Diabetes

Endocrine Genetics (P.V., H.O.-B., M.P., R.G., M.R., C.P.) and Molecular Endocrinology (C.G.G.) Laboratories, McGill University-Montreal Children’s Hospital Research Institute; and Department of Pediatrics, Division of Endocrinology (P.V., H.O.-B., M.P., R.G., M.R., C.G.G., C.P.), McGill University, Montreal, Quebec, Canada H3H 1P3

Address all correspondence and requests for reprints to: Dr. Constantin Polychronakos, Endocrine Genetics Laboratory, McGill University, Montreal Children’s Hospital Research Institute, 2300 Tupper Street, Room E-316, Montreal, Quebec, Canada, H3H 1P3. E-mail cpolyc{at}po-box.mcgill.ca

Abstract

Type 1 diabetes results from autoimmune destruction of the insulin-producing pancreatic ß cells. The insulin gene (INS) is also expressed in human thymus, an ectopic expression site likely involved in immune tolerance. The IDDM2 diabetes susceptibility locus maps to a minisatellite composed of a variable number of tandem repeats situated 0.5 kb upstream of INS. Chromosomes carrying the protective long INS variable number of tandem repeats alleles (class III) produce higher levels of thymic INS mRNA than those with the predisposing, short class I alleles. However, complete silencing of thymic INS transcripts from the class III chromosome was found in a small proportion of heterozygous human thymus samples. We hypothesized that the specific class III alleles found on these chromosomes silence rather than enhance thymic insulin expression. To test the prediction that these alleles are predisposing, we developed a DNA fingerprinting method for detecting two putative "silencing" alleles found in two thymus samples (S1, S2). In a set of 287 diabetic children and their parents we found 13 alleles matching the fingerprint of the S1 or S2 alleles. Of 18 possible transmissions, 12 of the S1–S2 alleles were transmitted to the diabetic offspring, a frequency of 0.67, significantly higher than the 0.38 seen in the remaining 142 class III alleles; P = 0.025. This confirms our prediction and represents an additional level of correlation between thymic insulin and diabetes susceptibility, which supports a thymic enhancer effect of the INS variable number of tandem repeats as the mechanism of IDDM2 and refines the contribution of IDDM2 genotyping to diabetes risk assessment.

This article has been cited by other articles:

				B. Faideau, J.-P. Briand, C. Lotton, I. Tardivel, P. Halbout, J. Jami, J. F. Elliott, P. Krief, S. Muller, C. Boitard, et al. Expression of Preproinsulin-2 Gene Shapes the Immune Response to Preproinsulin in Normal Mice J. Immunol., January 1, 2004; 172(1): 25 - 33. [Abstract] [Full Text] [PDF]

				M A Kelly, M L Rayner, C H Mijovic, and A H Barnett Molecular aspects of type 1 diabetes Mol. Pathol., February 1, 2003; 56(1): 1 - 10. [Abstract] [Full Text] [PDF]